You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Search results for: 'active'
RecombinantFGF-8f,Human [orb1494873]> 95% by SDS-PAGE analysis.
25.5 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg- RecombinantFGF-8e,Human [orb1494874]
> 95% as analyzed by SDS-PAGE
24.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantFGF-8c,Mouse [orb1494875]
> 95% by SDS-PAGE and HPLC analyses.
28.2 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantFGF-8a,Human [orb1494876]
> 95% by SDS-PAGE analysis.
21.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 10 μg, 50 μg - RecombinantFGF-8,Human [orb1494877]
> 95% by SDS-PAGE and HPLC analyses.
22.5kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantFGF-6,Human [orb1494878]
> 95% as analyzed by SDS-PAGE and HPLC.
18.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantFGF-4,Human [orb1494879]
> 95% by SDS-PAGE and HPLC analyses.
19.4kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 100 μg - RecombinantFGF-21,Mouse [orb1494880]
> 97% as analyzed by SDS-PAGE& HPLC.
19.9 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantFGF-21,Human [orb1494881]
> 95% as analyzed by SDS-PAGE and HPLC.
19.5 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantFGF-18,Rat [orb1494882]
> 95% as analyzed by SDS-PAGE and HPLC.
20.1 kDa, observed by non-reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg